In previous chapters, we identified the nature of the pharmacokinetic profile for a series of controlled-release systems. The zero-order release represented a simple, idealized, gradual release response, which allowed for a predicted dosage to be delivered over a predictable time regime. As we shifted our discussion to encapsulated and targeted systems, it became apparent that the zero-order release would be less relevant since the design strategy for these systems is to prevent interaction between the drug and physiological environment until the drug reaches the tissue target. Upon reaching the target, the system is either consumed or degraded in order to release the drug dosage form into the cellular environment. An important question that arises at this point in the discussion is
What facilitates the release of drug into the cellular environment?In Chap. 5, we identified the targeting groups on the surface of self-emulsifying systems that contribute to their adhesion and consumption by cellular species through receptor-mediated endocytosis or macropinocytosis. In our previous discussion, we assumed that the vesicle or micelle was being either destabilized or degraded within the cell lysosomes to release the drug into the intracellular environment. This approach has some functional limitations since it consists of several factors that are dependent on cellular function and response. The analogy would be when you fly on a plane and arrive at a destination, one surefire way to know that you have arrived, aside from the landing, is that the doors open and people leave. Can you imagine an airline where the plane would have to erode completely, or worse crash, before you were permitted to leave? For this precise reason, it is often